Eight Annual Brain Mapping Day at the US Congress
8th Annual Brain Mapping Day at the US Congress is a joint event between the Congressional Neuroscience Caucus and the Society for Brain Mapping and Therapeutics (SBMT), Brain Mapping Foundation and National Center for NanoBioElectronics aimed at educating policymakers about the state-of-the art diagnostics and therapeutics in clinical translational neuroscience.
Thursday – February 28th, 2019, 12PM noon - 3PM EST
Rayburn Building 2044,
United States Congress, Washington DC, USA,
Theme: Brain Health, Opioid, Mental and Neurotechnology.
View Congressional Invitation Letter
Babak Kateb, MD, Chairman of the Board of Society for Brain Mapping and Therapeutics (SBMT) | President of Brain Mapping Foundation (BMF) | Director of Brain Technology and Innovation Park (BTIP) Initiative | Director of National Center for NanoBioElectronics (NCNBE) | CEO of Smart Microscopy, Inc. | Chairman| Neuroscience-20/G20 Summit World Brain Mapping and Therapeutics Initiative | California | USA
Opening Remarks by Neuroscience Caucus Co-chairs:
The Human and the Financial Impact of Severe Head Injury in the US
Saleem Abdulrauf, M.D.
Professor and Chairman of Neurosurgery at St. Luis University Hospital, School of Medicine; President Elect of Society for Brain Mapping and Therapeutics (SBMT), President of Walter A. Dandy Society
Violence, Compassion, and the Brain
Jeremy G. Richman, Ph.D.
Founder & CEO, The Avielle Foundation
Dr. Richman is a neuro-pharmacologist with more than 20 years of research and drug discovery experience. Dr. Richman’s daughter was murdered in the Sandy Hook Elementary School massacre
Spine care and opioid. What is wrong with the system?
Philip Schneider, MD,
Orthopedic/Spine Surgeon, Director of NASS Advocacy Council, North American Spine Society (NASS)
Opioid Epidemic: Innovations In Treatment
Daniel P. Sipple, D.O, F.A.B.M.R, D.A.B.P.M
Member of the Board of Society for Brain Mapping and Therapeutics (SBMT); Apple Valley Medical Center, MN,
Dr. Daniel Sipple is an expert in conservative management of a variety of spinal, musculoskeletal, and pain conditions.
Accelerating Drug Repositioning to Deliver Value Based Neurotherapeutics
Howard Federoff, M.D., Ph.D
Professor of Neurology at University of California, Irvine - College of Medicine, CA
Predictive modeling and AI for AD (Alzheimer's Disease): Early detection and early intervention
Mark Ereth, M.D.
Professor Emeritus, Mayo Clinic College of Medicine, MN
Need Predictability in the Medical Device Ecosystem
Eric Muehlbauer, MJ, CAE,
Executive Director and CEO, North American Spine Society (NASS), IL
Overview of the White House Office of Science Technology and Policy (OSTP)
Kelvin Droegemeier, Ph.D.
Director of the White House Office of Science, Technology and Policy (OSTP)
Convergence of computation and neurotechnology to accelerate discovery and enable cures
Serge Braun, Ph.D.
Chief Scientist, AFM-Telethon, France, Paris.
A pioneering non-profit/biotech park in Paris, which has introduced many new therapeutics and drugs for motor neuron diseases.
1:15-2:00 PM:Q/A and Panel Discussion Moderated by:
Babak Kateb, MD
Ken Green, DMD,,Commander, US Navy (Retired), Vice President of Brain Mapping Foundation
Indira Sakibova MBA, Policy Fellow, Society for Brain Mapping and Therapeutic (SBMT),
Warren Boling, MD, Immediate Past President and Member of the Executive Board of SBMT, Professor and Chairman of Neurosurgery, Loma Linda University Medical Center.
Please RSVP with Ms. Indira Sakibova, SBMT Policy Fellow at: firstname.lastname@example.org